Form D — Iaso Therapeutics, Inc.
0000905729-26-000020 · filed Jan 14, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,800,000
- Reported amount sold
- $570,000
- Minimum investment
- $25,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Iaso Therapeutics, Inc.
- CIK
- 1961165
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4942 DAWN AVE
EAST LANSING, Michigan 48823 - Phone
- 773-437-0274
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Forgey · Executive OfficerEAST LANSING, Michigan Find on LinkedIn ↗
-
Xuefei Huang · Executive OfficerEast Lansing, Michigan Find on LinkedIn ↗
-
Steve Kuemmerie · DirectorEast Lansing, Michigan Find on LinkedIn ↗
-
Jeffrey Wesley · DirectorEast Lansing, Michigan Find on LinkedIn ↗
-
Donald Parfet · DirectorEast Lansing, Michigan Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗